role of furosemide in transient tachypnea of newborn

THE EFFECT OF I/V FUROSEMIDE ON MEAN HOSPITAL STAY AND RATE OF MORTALITY IN TRANSIENT TACHYPNEA OF NEWBORN

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240601061974N1

Enrollment

Registered

2024-06-08

Start date

2024-06-05

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient tachypnea of newborn.

Interventions

Intervention 1: Intervention group:. Intervention 2: Control group:.

Eligibility

Sex/Gender

All

Age

1 Days to 28 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria included all full term diagnosed with Transient tachypnea of newborn of both sex born via either caesarian section and spontaneous vaginal delivery. late preterm infants diagnosed with Transient tachypnea of newborn of both sex born via either caesarian section and spontaneous vaginal delivery.

Exclusion criteria

Exclusion criteria: Patients of respiratory distress but not under umbrella of Transient tachypnea of newborn. Patients of Meconium aspiration (Cord and skin stained with meconium , Chest x-rays showing lung opacities and hyperinflation of lungs) Patients of Patients of Pneumonia (consolidations) Patients of Neonatal Respiratory Distress Syndrome(NRDS) (Air bronchograms on CXR), Patients of Neonatal Sepsis(early onset) (positive C reactive protein) Patients of Hypoglycemia (BSR less than 54mg/dl respectively) Patients of Polycythemia(Hematocrit greater than 60%) Patients of Heart Murmur ( via auscultation ) Patients of Tachycardia (heart rate greater than 180/min)

Design outcomes

Primary

Measure	Time frame
I/V feurosemide decreases the mean hospital stay in TTN. Timepoint: 1-2 days. Method of measurement: heart rate using cardia monitor.	—

Countries

Pakistan

Contacts

Public ContactSohail shahzad

cmh bahawalpur

sohailshahzad55@yahoo.com+92 62 2501742

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026